Allworth Financial LP Karuna Therapeutics, Inc. Transaction History

Allworth Financial LP

  • $16.1 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 24, 2024
BUY
$161.01 - $317.85 $2,576 - $5,085
16 Added 160.0%
26 $8,000
Q3 2023

Oct 31, 2023
BUY
$164.66 - $218.08 $164 - $218
1 Added 11.11%
10 $1,000
Q1 2023

Apr 18, 2023
SELL
$161.33 - $204.36 $161 - $204
-1 Reduced 10.0%
9 $1,000
Q3 2022

Oct 18, 2022
BUY
$123.79 - $277.42 $1,114 - $2,496
9 Added 900.0%
10 $2,000
Q2 2022

Jul 13, 2022
BUY
$93.97 - $143.33 $93 - $143
1 New
1 $0

Others Institutions Holding KRTX

# of Institutions
10
Shares Held
332K
Call Options Held
0
Put Options Held
0
View Full List

About Karuna Therapeutics, Inc.

KRTX Quotes by TradingView
  • Ticker KRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 33,965,000
  • Description
  • Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...
More about KRTX
Track This Portfolio

Track Allworth Financial LP Portfolio

Follow Allworth Financial LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allworth Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Allworth Financial LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email